VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification
View abstract on PubMed
Summary
This summary is machine-generated.The vitamin D receptor (VDR) acts as a potential cancer biomarker. VDR expression impacts prognosis and immune cell infiltration across many human cancers, with validated roles in thyroid cancer.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- The vitamin D receptor (VDR) is crucial for vitamin D's biological effects.
- Evidence suggests VDR's role in cancer suppression, but findings in human cancers are conflicting.
- A comprehensive pan-cancer analysis of VDR's role is lacking.
Purpose Of The Study
- To investigate the relationship between VDR expression and cancer prognosis, immune infiltration, and the tumor microenvironment (TME) across 33 human cancer types.
- To experimentally validate VDR's role in papillary thyroid cancer (PTC).
Main Methods
- Utilized public databases and R software for pan-cancer analysis.
- Performed gene set enrichment analysis (GSEA).
- Conducted experimental validation in papillary thyroid cancer models.
Main Results
- VDR expression varied across cancer types, decreasing in 8 and increasing in 12 compared to normal tissues.
- Increased VDR expression correlated with both good and poor prognoses in 13 cancer types.
- VDR positively correlated with immune cell infiltration (fibroblasts, macrophages, neutrophils) and stromal/immune components in the TME in numerous cancers.
- VDR expression was elevated in PTC, inhibiting proliferation and migration.
- GSEA revealed enrichment in immune cell function and energy metabolism pathways.
Conclusions
- VDR serves as a potential prognostic biomarker in human cancers.
- VDR expression is linked to immune infiltration and TME composition.
- VDR plays a validated role in papillary thyroid cancer, affecting proliferation and migration.

